Re-evaluate disease status following immunotherapy intolerance: Stage III melanoma. There is no evidence of intracranial hemorrhage, mass, or acute infarct. There is unchanged minimal cerebral white matter T2 hyperintensity. There is no abnormal intracranial enhancement. The ventricles and basal cisterns are normal in size and configuration. There is no midline shift or herniation. The major cerebral flow voids are intact. The orbits, skull, paranasal sinuses, and scalp soft tissues are unchanged, including a probable hemangioma in the left parietal calvarium.
No evidence of intracranial metastases.